AzTrials
AzTrials

Instrument-assisted Soft Tissue MobilizationNCT06529926

Investigation of The Effect of "Instrument-Assisted Soft Tissue Mobilization" in Individuals With Lumbar Disc Herniation

A study testing Observational and IASTM Technique Application in people with Instrument-assisted Soft Tissue Mobilization and Treatment, run by Inonu University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Instrument-assisted soft tissue mobilization is an instrument-assisted soft tissue mobilization technique. It consists of stainless steel instrument designed to adapt to various tissues/shapes/curves of the body. The instruments were developed as an alternative to transverse friction massage. Read more about this study

Who is it for?
Ages 20 to 60 years
What is being tested?
Observational and IASTM Technique Application
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Nov 2017to 31 Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Individuals have been diagnosed with LDH,
  • Their pain is 3 and above according to the Visual Analog Scale (VAS),
  • They are between the ages of 20-60,
  • Their clinical status is stable,
  • They are fully cooperative,
  • They do not have cognitive, cognitive and mental problems and they can express themselves,
  • They voluntarily agree to participate in the study.

Who cannot join

  • Individuals have psychological disorders, mental disorders, cancer and severe depression,
  • Primary or metastatic spinal malignancy,
  • Have been diagnosed with advanced osteoporosis,
  • Have recently undergone surgical intervention or acute infection,
  • Cannot or do not want to perform tests or treatment exercises,
  • Want to leave voluntarily.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Inonu University

    Malatya, 44280

Other trials in Turkey (Türkiye)

About this study

Instrument-assisted soft tissue mobilization is an instrument-assisted soft tissue mobilization technique. It consists of stainless steel instrument designed to adapt to various tissues/shapes/curves of the body. The instruments were developed as an alternative to transverse friction massage. Stainless steel acts a bit like a diaposon when it comes into contact with fibrotic tissue. A resonance or reverberation in the instrument is created upon contact and transmitted through the instrument to the hands of the clinician. The application of heavy pressure (compared to light or medium pressure) using instruments has been proven to promote a greater fibroblastic response.

Instrument-assisted soft tissue mobilization is not used without insulation. It is imperative to use movement and strengthening in combination with soft tissue mobilization to promote tissue adaptation and remodeling. Mechanical loading has been shown to affect chondrocyte alignment and fibroblast activity with increased proteoglycan and collagen synthesis. The aim of this study was to investigate the effects of the IASTM technique on individuals of different ages diagnosed with LDH.

Being tested
Observational, IASTM Technique Application
Medical subject headings
Motor Activity, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ObservationalOther

    Only classical physiotherapy application for 4 weeks.

  • IASTM Technique ApplicationOther

    IASTM application for 2 sessions per week with classical physiotherapy for 4 weeks.

Study groups in NCT06529926
Study groupRoleWhat they receive
Control GroupOtherTreated with classical physiotherapy (Hotpack+TENS+Ultrasound) program. A 20-minute hotpack was applied to the lumbar area. TENS and ultrasound were applied as electrotherapy agents. The TENS application was made with the Chattanooga Intelect Advanced Combo device. Conventional tens was applied at a frequency of 100 Hz for 20 min with a current of 100 μs. The ultrasound application was made with the Chattanooga Intelect Advanced Combo device. Lumbar area was administered at a dose of 1 MHz, 1.5 W/cm² using a 5 cm diameter cap for 6 min. In the first session, the physiotherapist had the patient explain the exercises (posterior pelvic tilt exercise, hip flexors stretching exercise, lumbar extensors stretching exercise, abdominal muscle strengthening exercise, SLR exercise, pelvic elevation exercise, cat-camel exercise and lumbar extensor strengthening exercise). Afterwards, patients were advised to rest for 1 minute between exercises, 1 time a day and for 4 weeks, 5 days a week.
Receives: Other: Observational
IASTM Treatment GroupExperimentalIASTM application was applied at an angle of 45° in a direction parallel to the muscle fibers for about 20 seconds. Immediately afterwards, a total of 40 seconds of treatment time was applied by treating the muscle fibers at a 45° angle with the instrument for an additional 20 seconds in a direction perpendicular to them. In other words, for each area (paraspinal muscles, gluteus maximus and gluteus medius muscles, hamstrings), a total of 2 minutes was applied to the right and left sides separately for 40x3 seconds. Paraspinal muscles were treated from caudal to cranium, gluteal muscles from proximal to distal and hamstring muscles from popliteal fossa to gluteal line. Stretching was provided by exercises applied to the control group. After the cold application, IASTM application was made, the cold-pack was applied to each area for 5 minutes. (The application was performed by a trained and experienced physiotherapist and with a stainless steel gua sha device).
Receives: Other: IASTM Technique Application

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluation of Pain

    Visual analog scale was used to evaluate the pain of the patients.

    Measured: Pre-treatment assessment.

  2. Evaluation of Pain

    Visual analog scale was used to evaluate the pain of the patients.

    Measured: After 4 weeks of treatment (Post-treatment assessment).

  3. Evaluation of Pain

    Visual analog scale was used to evaluate the pain of the patients.

    Measured: 2nd month post-treatment assessment.

  4. Evaluation of Functional Status (Straight leg raise test)

    Straight leg raise test was used to evaluate the functional status of the patients.

    Measured: Pre-treatment assessment.

  5. Evaluation of Functional Status (Straight leg raise test)

    Straight leg raise test was used to evaluate the functional status of the patients.

    Measured: After 4 weeks of treatment (Post-treatment assessment).

  6. Evaluation of Functional Status (Straight leg raise test)

    Straight leg raise test was used to evaluate the functional status of the patients.

    Measured: 2nd month post-treatment assessment.

  7. Evaluation of Functional Status (Slump test)

    Slump test was used to evaluate the functional status of the patients.

    Measured: Pre-treatment assessment.

  8. Evaluation of Functional Status (Slump test)

    Slump test was used to evaluate the functional status of the patients.

    Measured: After 4 weeks of treatment (Post-treatment assessment).

  9. Evaluation of Functional Status (Slump test)

    Slump test was used to evaluate the functional status of the patients.

    Measured: 2nd month post-treatment assessment.

  10. Evaluation of Functional Status (5-min walking test)

    5-min walking test was used to evaluate the functional status of the patients.

    Measured: Pre-treatment assessment.

  11. Evaluation of Functional Status (5-min walking test)

    5-min walking test was used to evaluate the functional status of the patients.

    Measured: After 4 weeks of treatment (Post-treatment assessment).

  12. Evaluation of Functional Status (5-min walking test)

    5-min walking test was used to evaluate the functional status of the patients.

    Measured: 2nd month post-treatment assessment.

  13. Evaluation of Normal Joint ROM

    Goniometer was used to evaluate the normal joint ROM of the patients.

    Measured: Pre-treatment assessment.

  14. Evaluation of Normal Joint ROM

    Goniometer was used to evaluate the normal joint ROM of the patients.

    Measured: After 4 weeks of treatment (Post-treatment assessment).

  15. Evaluation of Normal Joint ROM

    Goniometer was used to evaluate the normal joint ROM of the patients.

    Measured: 2nd month post-treatment assessment.

  16. Evaluation of Quality of Life

    Short Form-36 was used to evaluate the quality of life of the patients.

    Measured: Pre-treatment assessment.

  17. Evaluation of Quality of Life

    Short Form-36 was used to evaluate the quality of life of the patients.

    Measured: After 4 weeks of treatment (Post-treatment assessment).

  18. Evaluation of Quality of Life

    Short Form-36 was used to evaluate the quality of life of the patients.

    Measured: 2nd month post-treatment assessment.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jul 2024
  2. Study start1 Nov 2017
  3. Primary completion1 Dec 2018
  4. Study completion31 Dec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06529926
Sponsor's protocol ID
ÜSAME TAŞ-004
Status last verified
Jul 2024
First submitted
21 Jul 2024
Last updated
31 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Observational and IASTM Technique Application in people with Instrument-assisted Soft Tissue Mobilization and Treatment, run by Inonu University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluation of Pain (time frame: Pre-treatment assessment.). The study lists 18 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in